Your location: Home > Program
Query:
Date:
  • All
  • 2025/10/31
  • 2025/11/01
  • 2025/11/02
Hall:
  • All
  • Second Floor,Beijing Room
  • Second Floor,London Room
  • Second Floor,Paris Room
  • Second Floor,Berlin Room
  • Second Floor,Rome Room
  • Second Floor,Madrid Room
  • Third Floor,VIP Room
  • 2th Reception area 1
  • 2th Reception area 2
  • Third Floor,Grand Ballroom 1+2
  • Second Floor,Seoul Room

2025/10/31

Third Floor,VIP Room

2025/10/31 13:30-15:14 Rising Star 7-General Topics
Moderator :
1 13:30-13:40 rising star

Allogeneic Universal CAR-T Therapy:A Revolutionary Breakthrough in Autoimmune Diseases

Yi Jin the second affiliated hospital of the naval medcal university
2 13:40-13:43 Discuss

Discussion

3 13:43-13:53 rising star

Characteristics and Risk Factors for Infection in Hospitalized Patients with Moderate to Severe Pemphigus: A Retrospective Study of 102 Patients

Xinyi Lu Peking Union Medical College Hospital
4 13:53-13:56 Discuss

Discussion

5 13:56-14:06 rising star

Characteristics And Prognostic Factors of Autoimmune Bullous Disease Associated With Immune Checkpoint Inhibitor

Min Zou West China Hospital of Sichuan University
6 14:06-14:09 Discuss

Discussion

7 14:09-14:19 rising star

Dysbiosis in acne vulgaris and hidradenitis suppurativa: A comparative microbiome analysis

Wanxin Chen Shanghai dermatological hospital
8 14:19-14:22 Discuss

Discussion

9 14:22-14:32 rising star

Minocycline inhibits rosacea-like inflammation through the TLR4-mediated NF-κB signaling pathway in vivo and in vitro

Piyan Hua The First Affiliated Hospital of Kunming Medical University
10 14:32-14:35 Discuss

Discussion

11 14:35-14:45 rising star

Single-Cell RNA Sequencing Unravels Neuro-Immune Mechanisms in Atopic Prurigo Nodularis

Quanhong Zhang Department of Dermatology, Wuhan No.1 hospital
12 14:45-14:48 Discuss

Discussion

13 14:48-14:58 rising star

Global burden of bacterial skin diseases from 1990 to 2045: an analysis based on global burden disease data

Jiaming Wang peking university shenzhen hospital
14 14:58-15:01 Discuss

Discussion

15 15:01-15:11 rising star

TSC22 domain family member 3 links natural killer cells to CD8+ T cell-mediated drug hypersensitivity

Lele Sun Dermatology Hospital of Shandong First Medical University
16 15:11-15:14 Discuss

Discussion

2025/10/31 15:24-16:55 Rising Star 7-General Topics
1 15:24-15:34 rising star

Echinatin regulate the ubiquitination degradation of DNAJC12 to alleviates NF-kb signal-mediated inflammatory skin diseases

Jia Yan Shanghai Skin Disease Hospital
2 15:34-15:37 Discuss

Discussion

3 15:37-15:47 rising star

Remodeling Lymphatic Vessels in Intrinsically Aged Skin on SKH-1 Mouse Using Low Dose 5-aminolevulinic Acid Photodynamic Therapy via VEGF-C/ VEGFR3 Pathway

Yuling Yang Shanghai Skin Disease Hospital
4 15:47-15:50 Discuss

Discussion

5 15:50-16:00 rising star

Alterations of intestinal barrier injury markers in patients with bullous pemphigoid

Ao Guo The Second Affiliated Hospital of Xi'an Jiaotong University
6 16:00-16:03 Discuss

Discussion

7 16:03-16:13 rising star

The effect of the antibody-mediated immune responses on hidradenitis suppurativa: a mendelian randomization study

Yuzhe Cheng China Medical University
8 16:13-16:16 Discuss

Discussion

9 16:16-16:26 rising star

Heating at 44°C suppressed proliferation and promoted apoptosis of keratinocyte , via PHLDA2 mediated inhibition of SRC/AKT pathway

Bowen Zheng Shengjing Hospital Of China Medical University
10 16:26-16:29 Discuss

Discussion

11 16:29-16:39 rising star

The RIPK1 S331 O-GlcNAc glycosylation mediated by O-GlcNAc transferase to promote keratinocyte necroptosis in the pathogenesis of severe drug eruption

Chen Zhang Department of Dermatology, Xijing Hospital, Fourth Military Medical University
12 16:39-16:42 Discuss

Discussion

13 16:42-16:52 rising star

Macrophage-driven Adipocyte Lipolysis Fuels Acne Fibrosis via TNF–TNFR Signaling

Yiman Liu State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian, China
14 16:52-16:55 Discuss

Discussion